The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Astragaloside IV Market Research Report 2025
Synopsis
Astragaloside IV extract from astragalus Root.
The global Astragaloside IV market was valued at US$ 72 million in 2023 and is anticipated to reach US$ 90 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Plant extracts are substances or active substances with desired properties extracted from plant tissue and processed for a specific purpose. It is used in various fields, such as health foods, therapeutic drugs, cosmetics, processing aids, additives chemical substitutes. The market’s growth is driven by lifestyle changes, consumer awareness, increasing use of products based on natural ingredients, and biotechnology breakthroughs. Additionally, macroeconomic variables such as rising consumer disposable income, research and development, imports and exports, growth in the agriculture industry, population aging, and population growth have positively impacted the demand for plant extracts in recent years. It is also becoming increasingly popular in cosmetics, perfumes, pharmaceuticals, and dietary supplements. The plant extracts market was valued at USD 31.84 billion in 2022 and is expected to grow at a CAGR of 11.3% during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Astragaloside IV, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Astragaloside IV.
Report Scope
The Astragaloside IV market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Astragaloside IV market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Astragaloside IV manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NandR Bio Industries
Zenergy Korea Corporation
Bio-norm
Wuhan Vanz Pharm
Shaanxi Pioneer Biotech
Xi'an Lyphar Biotech
Xian Pincredit Bio-Tech
Shaanxi Fuheng (FH) Biotechnology
Nanjing NutriHerb BioTech
Segment by Type
0.1
0.98
Others
Segment by Application
Food Industry
Pharmaceuticals Industry
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Astragaloside IV manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Astragaloside IV by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Astragaloside IV in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Astragaloside IV extract from astragalus Root.
The global Astragaloside IV market was valued at US$ 72 million in 2023 and is anticipated to reach US$ 90 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.
Plant extracts are substances or active substances with desired properties extracted from plant tissue and processed for a specific purpose. It is used in various fields, such as health foods, therapeutic drugs, cosmetics, processing aids, additives chemical substitutes. The market’s growth is driven by lifestyle changes, consumer awareness, increasing use of products based on natural ingredients, and biotechnology breakthroughs. Additionally, macroeconomic variables such as rising consumer disposable income, research and development, imports and exports, growth in the agriculture industry, population aging, and population growth have positively impacted the demand for plant extracts in recent years. It is also becoming increasingly popular in cosmetics, perfumes, pharmaceuticals, and dietary supplements. The plant extracts market was valued at USD 31.84 billion in 2022 and is expected to grow at a CAGR of 11.3% during the forecast period.
This report aims to provide a comprehensive presentation of the global market for Astragaloside IV, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Astragaloside IV.
Report Scope
The Astragaloside IV market size, estimations, and forecasts are provided in terms of output/shipments (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Astragaloside IV market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Astragaloside IV manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
NandR Bio Industries
Zenergy Korea Corporation
Bio-norm
Wuhan Vanz Pharm
Shaanxi Pioneer Biotech
Xi'an Lyphar Biotech
Xian Pincredit Bio-Tech
Shaanxi Fuheng (FH) Biotechnology
Nanjing NutriHerb BioTech
Segment by Type
0.1
0.98
Others
Segment by Application
Food Industry
Pharmaceuticals Industry
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Mexico
Brazil
Turkey
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Astragaloside IV manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Astragaloside IV by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Astragaloside IV in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Index1 Astragaloside IV Market Overview
1.1 Product Definition
1.2 Astragaloside IV Segment by Type
1.2.1 Global Astragaloside IV Market Value Growth Rate Analysis by Type 2023 VS 2030
1.2.2 0.1
1.2.3 0.98
1.2.4 Others
1.3 Astragaloside IV Segment by Application
1.3.1 Global Astragaloside IV Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Food Industry
1.3.3 Pharmaceuticals Industry
1.3.4 Others
1.4 Global Market Growth Prospects
1.4.1 Global Astragaloside IV Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Astragaloside IV Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Astragaloside IV Production Estimates and Forecasts (2019-2030)
1.4.4 Global Astragaloside IV Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Astragaloside IV Production Market Share by Manufacturers (2019-2024)
2.2 Global Astragaloside IV Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Astragaloside IV, Industry Ranking, 2022 VS 2023 VS 2024
2.4 Global Astragaloside IV Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Astragaloside IV Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Astragaloside IV, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Astragaloside IV, Product Offered and Application
2.8 Global Key Manufacturers of Astragaloside IV, Date of Enter into This Industry
2.9 Astragaloside IV Market Competitive Situation and Trends
2.9.1 Astragaloside IV Market Concentration Rate
2.9.2 Global 5 and 10 Largest Astragaloside IV Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Astragaloside IV Production by Region
3.1 Global Astragaloside IV Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Astragaloside IV Production Value by Region (2019-2030)
3.2.1 Global Astragaloside IV Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Astragaloside IV by Region (2025-2030)
3.3 Global Astragaloside IV Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Astragaloside IV Production by Region (2019-2030)
3.4.1 Global Astragaloside IV Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Astragaloside IV by Region (2025-2030)
3.5 Global Astragaloside IV Market Price Analysis by Region (2019-2024)
3.6 Global Astragaloside IV Production and Value, Year-over-Year Growth
3.6.1 North America Astragaloside IV Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Astragaloside IV Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Astragaloside IV Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Astragaloside IV Production Value Estimates and Forecasts (2019-2030)
4 Astragaloside IV Consumption by Region
4.1 Global Astragaloside IV Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Astragaloside IV Consumption by Region (2019-2030)
4.2.1 Global Astragaloside IV Consumption by Region (2019-2024)
4.2.2 Global Astragaloside IV Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Astragaloside IV Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Astragaloside IV Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Astragaloside IV Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Astragaloside IV Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Astragaloside IV Consumption Growth Rate by Region: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Astragaloside IV Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Astragaloside IV Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Astragaloside IV Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Astragaloside IV Production by Type (2019-2030)
5.1.1 Global Astragaloside IV Production by Type (2019-2024)
5.1.2 Global Astragaloside IV Production by Type (2025-2030)
5.1.3 Global Astragaloside IV Production Market Share by Type (2019-2030)
5.2 Global Astragaloside IV Production Value by Type (2019-2030)
5.2.1 Global Astragaloside IV Production Value by Type (2019-2024)
5.2.2 Global Astragaloside IV Production Value by Type (2025-2030)
5.2.3 Global Astragaloside IV Production Value Market Share by Type (2019-2030)
5.3 Global Astragaloside IV Price by Type (2019-2030)
6 Segment by Application
6.1 Global Astragaloside IV Production by Application (2019-2030)
6.1.1 Global Astragaloside IV Production by Application (2019-2024)
6.1.2 Global Astragaloside IV Production by Application (2025-2030)
6.1.3 Global Astragaloside IV Production Market Share by Application (2019-2030)
6.2 Global Astragaloside IV Production Value by Application (2019-2030)
6.2.1 Global Astragaloside IV Production Value by Application (2019-2024)
6.2.2 Global Astragaloside IV Production Value by Application (2025-2030)
6.2.3 Global Astragaloside IV Production Value Market Share by Application (2019-2030)
6.3 Global Astragaloside IV Price by Application (2019-2030)
7 Key Companies Profiled
7.1 NandR Bio Industries
7.1.1 NandR Bio Industries Astragaloside IV Corporation Information
7.1.2 NandR Bio Industries Astragaloside IV Product Portfolio
7.1.3 NandR Bio Industries Astragaloside IV Production, Value, Price and Gross Margin (2019-2024)
7.1.4 NandR Bio Industries Main Business and Markets Served
7.1.5 NandR Bio Industries Recent Developments/Updates
7.2 Zenergy Korea Corporation
7.2.1 Zenergy Korea Corporation Astragaloside IV Corporation Information
7.2.2 Zenergy Korea Corporation Astragaloside IV Product Portfolio
7.2.3 Zenergy Korea Corporation Astragaloside IV Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Zenergy Korea Corporation Main Business and Markets Served
7.2.5 Zenergy Korea Corporation Recent Developments/Updates
7.3 Bio-norm
7.3.1 Bio-norm Astragaloside IV Corporation Information
7.3.2 Bio-norm Astragaloside IV Product Portfolio
7.3.3 Bio-norm Astragaloside IV Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Bio-norm Main Business and Markets Served
7.3.5 Bio-norm Recent Developments/Updates
7.4 Wuhan Vanz Pharm
7.4.1 Wuhan Vanz Pharm Astragaloside IV Corporation Information
7.4.2 Wuhan Vanz Pharm Astragaloside IV Product Portfolio
7.4.3 Wuhan Vanz Pharm Astragaloside IV Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Wuhan Vanz Pharm Main Business and Markets Served
7.4.5 Wuhan Vanz Pharm Recent Developments/Updates
7.5 Shaanxi Pioneer Biotech
7.5.1 Shaanxi Pioneer Biotech Astragaloside IV Corporation Information
7.5.2 Shaanxi Pioneer Biotech Astragaloside IV Product Portfolio
7.5.3 Shaanxi Pioneer Biotech Astragaloside IV Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Shaanxi Pioneer Biotech Main Business and Markets Served
7.5.5 Shaanxi Pioneer Biotech Recent Developments/Updates
7.6 Xi'an Lyphar Biotech
7.6.1 Xi'an Lyphar Biotech Astragaloside IV Corporation Information
7.6.2 Xi'an Lyphar Biotech Astragaloside IV Product Portfolio
7.6.3 Xi'an Lyphar Biotech Astragaloside IV Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Xi'an Lyphar Biotech Main Business and Markets Served
7.6.5 Xi'an Lyphar Biotech Recent Developments/Updates
7.7 Xian Pincredit Bio-Tech
7.7.1 Xian Pincredit Bio-Tech Astragaloside IV Corporation Information
7.7.2 Xian Pincredit Bio-Tech Astragaloside IV Product Portfolio
7.7.3 Xian Pincredit Bio-Tech Astragaloside IV Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Xian Pincredit Bio-Tech Main Business and Markets Served
7.7.5 Xian Pincredit Bio-Tech Recent Developments/Updates
7.8 Shaanxi Fuheng (FH) Biotechnology
7.8.1 Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Corporation Information
7.8.2 Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Product Portfolio
7.8.3 Shaanxi Fuheng (FH) Biotechnology Astragaloside IV Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Shaanxi Fuheng (FH) Biotechnology Main Business and Markets Served
7.7.5 Shaanxi Fuheng (FH) Biotechnology Recent Developments/Updates
7.9 Nanjing NutriHerb BioTech
7.9.1 Nanjing NutriHerb BioTech Astragaloside IV Corporation Information
7.9.2 Nanjing NutriHerb BioTech Astragaloside IV Product Portfolio
7.9.3 Nanjing NutriHerb BioTech Astragaloside IV Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Nanjing NutriHerb BioTech Main Business and Markets Served
7.9.5 Nanjing NutriHerb BioTech Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Astragaloside IV Industry Chain Analysis
8.2 Astragaloside IV Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Astragaloside IV Production Mode & Process
8.4 Astragaloside IV Sales and Marketing
8.4.1 Astragaloside IV Sales Channels
8.4.2 Astragaloside IV Distributors
8.5 Astragaloside IV Customers
9 Astragaloside IV Market Dynamics
9.1 Astragaloside IV Industry Trends
9.2 Astragaloside IV Market Drivers
9.3 Astragaloside IV Market Challenges
9.4 Astragaloside IV Market Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
